Saturn V Capital Management LP Diversified Active

CIK: 0001964437 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value ($000): $455,971 (100.0% shares, 0.0% debt)

Holdings (17)

ABVX ABIVAX SA 14.9%

Value ($000) $68,024 Shares 801,224 Est. Cost $29.41 Unrealized —

AMLX AMYLYX PHARMACEUTICALS INC 13.7%

Value ($000) $62,580 Shares 4,604,878 Est. Cost $5.73 Unrealized +64.4%

JAZZ JAZZ PHARMACEUTICALS PLC 8.7%

Value ($000) $39,620 Shares 300,610 Est. Cost $112.15 Unrealized +6.9%

DYN DYNE THERAPEUTICS INC 7.4%

Value ($000) $33,832 Shares 2,674,469 Est. Cost $11.19 Unrealized +1.9%

COGT COGENT BIOSCIENCES INC 6.4%

Value ($000) $29,080 Shares 2,025,041 Est. Cost $7.59 Unrealized +56.0%

PCVX VAXCYTE INC 6.2%

Value ($000) $28,400 Shares 788,441 Est. Cost $43.97 Unrealized -24.7%

CELC CELCUITY INC 5.1%

Value ($000) $23,407 Shares 473,828 Est. Cost $15.84 Unrealized +152.6%

CGON CG ONCOLOGY INC 5.1%

Value ($000) $23,358 Shares 579,895 Est. Cost $34.79 Unrealized -16.4%

IRON DISC MEDICINE INC 4.9%

Value ($000) $22,526 Shares 340,897 Est. Cost $47.97 Unrealized +24.0%

PHVS PHARVARIS N V 4.8%

Value ($000) $22,114 Shares 886,332 Est. Cost $22.18 Unrealized 0.0%

XENE XENON PHARMACEUTICALS INC 4.4%

Value ($000) $20,224 Shares 503,701 Est. Cost $39.36 Unrealized -10.5%

CNTA CENTESSA PHARMACEUTICALS PLC 3.9%

Value ($000) $17,813 Shares 734,539 Est. Cost $13.84 Unrealized —

— MERUS N V 3.8%

Value ($000) $17,336 Shares 184,135 Est. Cost $35.99 Unrealized —

LENZ LENZ THERAPEUTICS INC 3.8%

Value ($000) $17,150 Shares 368,176 Est. Cost $27.87 Unrealized +31.9%

OCUL OCULAR THERAPEUTIX INC 3.0%

Value ($000) $13,463 Shares 1,151,686 Est. Cost $9.62 Unrealized +24.4%

MNPR MONOPAR THERAPEUTICS INC 2.8%

Value ($000) $12,689 Shares 155,370 Est. Cost $44.70 Unrealized 0.0%

NAMS NEWAMSTERDAM PHARMA COMPANY 1.0%

Value ($000) $4,356 Shares 153,147 Est. Cost $19.89 Unrealized +20.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ABVX	ABIVAX SA	801,224	$68,024	14.9%	$29.41	—	SPONSORED ADS	00370M103
AMLX	AMYLYX PHARMACEUTICALS INC	4,604,878	$62,580	13.7%	$5.73	+64.4%	COM	03237H101
JAZZ	JAZZ PHARMACEUTICALS PLC	300,610	$39,620	8.7%	$112.15	+6.9%	SHS USD	G50871105
DYN	DYNE THERAPEUTICS INC	2,674,469	$33,832	7.4%	$11.19	+1.9%	COM	26818M108
COGT	COGENT BIOSCIENCES INC	2,025,041	$29,080	6.4%	$7.59	+56.0%	COM	19240Q201
PCVX	VAXCYTE INC	788,441	$28,400	6.2%	$43.97	-24.7%	COM	92243G108
CELC	CELCUITY INC	473,828	$23,407	5.1%	$15.84	+152.6%	COM	15102K100
CGON	CG ONCOLOGY INC	579,895	$23,358	5.1%	$34.79	-16.4%	COM	156944100
IRON	DISC MEDICINE INC	340,897	$22,526	4.9%	$47.97	+24.0%	COM	254604101
PHVS	PHARVARIS N V	886,332	$22,114	4.8%	$22.18	0.0%	COM	N69605108
XENE	XENON PHARMACEUTICALS INC	503,701	$20,224	4.4%	$39.36	-10.5%	COM	98420N105
CNTA	CENTESSA PHARMACEUTICALS PLC	734,539	$17,813	3.9%	$13.84	—	SPONSORED ADS	152309100
—	MERUS N V	184,135	$17,336	3.8%	$35.99	—	COM	N5749R100
LENZ	LENZ THERAPEUTICS INC	368,176	$17,150	3.8%	$27.87	+31.9%	COM	52635N103
OCUL	OCULAR THERAPEUTIX INC	1,151,686	$13,463	3.0%	$9.62	+24.4%	COM	67576A100
MNPR	MONOPAR THERAPEUTICS INC	155,370	$12,689	2.8%	$44.70	0.0%	COM NEW	61023L207
NAMS	NEWAMSTERDAM PHARMA COMPANY	153,147	$4,356	1.0%	$19.89	+20.5%	ORDINARY SHARES	N62509109